Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thandaserry Vasudevan Miji

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Current Gene Therapy|May 16, 2025
Elucidating the Predominant Role of AEBP1 in Different Types of Cancers with a Focus on Glioblastoma Progression - A ReviewRangaraj Kaviyaprabha, Sridhar Muthusami, Thandaserry Vasudevan Miji, et al.
Protein and Peptide Letters|March 25, 2025
Unveiling the Potential Role of Hesperetin and Emodin as a Combination Therapy to Inhibit the Pancreatic Cancer Progression against the C-Met GeneRangaraj Kaviyaprabha, Thandaserry Vasudevan Miji, Puthupparambil Shaji Sreelakshmi, et al.
Applied Biochemistry and Biotechnology|October 11, 2025
Inhibitory Effects of Hesperetin and EGCG in the Lung Cancer Progression involves impairment in TOP2A gene expression regulationRangaraj Kaviyaprabha, Thandaserry Vasudevan Miji, Unni Apsara, et al.
Current Cancer Drug Targets|September 18, 2024
Screening miRNAs to Hinder the Tumorigenesis of Renal Clear Cell Carcinoma Associated with KDR ExpressionRangaraj Kaviyaprabha, Thandaserry Vasudevan Miji, Rangaraj Suseela, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Current Gene Therapy|May 16, 2025
Elucidating the Predominant Role of AEBP1 in Different Types of Cancers with a Focus on Glioblastoma Progression - A ReviewRangaraj Kaviyaprabha, Sridhar Muthusami, Thandaserry Vasudevan Miji, et al.
Protein and Peptide Letters|March 25, 2025
Unveiling the Potential Role of Hesperetin and Emodin as a Combination Therapy to Inhibit the Pancreatic Cancer Progression against the C-Met GeneRangaraj Kaviyaprabha, Thandaserry Vasudevan Miji, Puthupparambil Shaji Sreelakshmi, et al.
Applied Biochemistry and Biotechnology|October 11, 2025
Inhibitory Effects of Hesperetin and EGCG in the Lung Cancer Progression involves impairment in TOP2A gene expression regulationRangaraj Kaviyaprabha, Thandaserry Vasudevan Miji, Unni Apsara, et al.
Current Cancer Drug Targets|September 18, 2024
Screening miRNAs to Hinder the Tumorigenesis of Renal Clear Cell Carcinoma Associated with KDR ExpressionRangaraj Kaviyaprabha, Thandaserry Vasudevan Miji, Rangaraj Suseela, et al.
Pageof 1